MAGGIO J; CARDAMA GA; BALCONE L; ARMANDO RG,; VILARULLO, ROMAN; MENGUAL GOMEZ DL,; D.E. GOMEZ

PIN1 as a molecular target for glioblastoma treatment: target validation, inhibitors rational design and biological activity determination

25th International Symposium on Molecular Medicine.

Año: 2023;

MAGGIO J; CARDAMA GA; ARMANDO RG,; D.E. GOMEZ; MENGUAL GOMEZ DL,

PIN1 validation as a molecular target for glioblastoma treatment

Reunion Anual de Sociedades de Biociencias. SAIC

Año: 2020;

PADERTA, CAMILA; MENGUAL GOMEZ DL,; CABRERA, MAIA; LORENZANO MENA P; D.E. GOMEZ; ARMANDO RG,

IN VITRO AND IN SILICO EVALUATION OF A NOVEL INHIBITOR OF TELOMERASE COMPLEX ASSEMBLY IN MDA MB 231 CELL LINE

LXV Reunión anual de la sociedad argentina de investigación clínica

Lugar: Mar del plata; Año: 2020;

SANMARTIN C; MENGUAL GOMEZ DL,; D.E. GOMEZ; ARMANDO RG,

EFFECT OF AZT TREATMENT ON PROTEINS VINCULATED TO TUMORAL DEVELOPMENT AND TERT EXTRA TELOMERIC ACTIVITIES IN THE HUMAN BREAST ADENOCARCINOMA CELL LINE MDA MB 231

Reunion Anual de Sociedades de Biociencias. SAIC

Año: 2019;

ARMANDO RG,; MENGUAL GOMEZ DL,; JURITZ E; LORENZANO MENNA P; D.E. GOMEZ

Novel strategy to inhibit telomerase for cancer treatment: Homology Modeling and Docking-Based Virtual Screening for Ligands of Human Dyskerin

A2B2C 10th Meeting

Lugar: Mendoza; Año: 2019;

ARMANDO RG,; MENGUAL GOMEZ DL,; LORENZANO MENNA P; D.E. GOMEZ

Develpment and activity of new inhibitors of dkc1-htr interaction on telomerase complex in a mammarytumor model.

EMBO telomere biology in health and human disease

Año: 2018;

ARMANDO RG; MENGUAL GOMEZ DL,; GOMEZ DE.

AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model".

EMBO Telomere, telomerase and disease meeting. Liége. Belgica. Abril 2016.

Lugar: Liege; Año: 2016;

ARMANDO RG,; MENGUAL GOMEZ DL, ; GOMEZ DE

Telomeropatie: a constellation of related genetic diseases caused by defects in the telomere maintenance machinery.

19th Symposium on Molecular Medicine

Lugar: Atenas; Año: 2016;

N GONZALEZ; CARDAMA GA; M.J. COMIN; V.I. SEGATORI; MARINA PIFANO; ALONSO DF; D.E. GOMEZ; LORENZANO MENNA P

. Pharmacological inhibition of RAC1.Pak1 axis restores tamoxifen sensitivity in human resistant breast cáncer cells.

61 Reunión Anual de la Sociedad Argentina de Investigación Clinica

Lugar: Mar del Plata; Año: 2016;

ARMANDO RG; MENGUAL GOMEZ DL; D.E. GOMEZ

New inhibitors of telomerase

20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine

Lugar: Atenas; Año: 2015;

GARONA J; MARINA PIFANO; PASTRIAN MB; IANUCCI NB; D.E. GOMEZ; GISELLE V RIPOLL; ADRIAN HUÑIS, DANIEL ALONSO, DANIEL E. GOMEZ

Antitumour activity of the desmopressin analogue [V4Q5]dDAVP, as single agent and in combination with chemotherapy, in V2r-expressing aggressive breast tumour models.

20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine

Lugar: Atenas; Año: 2015;

SAMPOR C; GUTHMANN MD; GABRI MR; LAGOMARSINO E; GALAR G; CACCIAVILLANO W; FAIMBOIN L; ALONSO DF; CHANTADA G; GOMEZ DE

A phase I study of racotumomab in pediatric refractory malignancies.

Pivac 13

Año: 2013;

SEGATORI VI; GOMEZ DE; ALONSO DF; GABRI MR

Racotumomab antitumor activity in the murine model of non small cell lung carcinoma 3LL is related with the level of expression on NGcGM3

103rd Annual Meeting of the American Associaton for Cancer Research

Lugar: Chicago; Año: 2012;

2007: H.G. FARINA, Y. PERERA, I. HERNÁNDEZ, O. MENDOZA, J.M. SERRANO, O. REYES, D.E. GOMEZ, R.E. GOMEZ, B.E. GOMEZ, D.F. ALONSO, S.E. PEREA

Systemic administration of a protein kinase (CK2) peptide inhibitor reduces solid tumor growth in mice.

American Association for Cancer Research

Lugar: USA; Año: 2007;

G. HERMO, P. TORRES, G.V. RIPOLL, D.E. GOMEZ, D.F. ALONSO, C. GOBELO

. Evaluation of perioperative desmopressin in dogs with spontaneous mammary gland tumors.

31st World Small Animal Veterinary Congress

Lugar: Praga, Czech Republic; Año: 2006;

P. LORENZANO MENNA, A. ZINNI, L. IGLESIAS, A. IRIBARREN, D.F. ALONSO, D.E. GOMEZ. .

Nuevos compuestos nucleosídicos anti-Rac con propiedades antimigratorias y antimetastásicas en un modelo de cáncer mamario.

Reunion Anual Sociedad Argentina de Investigacion Clinica

Lugar: Mar del Plata; Año: 2006;

L. OTERO, M. GABRI, V. SEGATORI, D.E. GOMEZ, D.F. ALONSO.

Modificación del comportamiento del melanoma B16 asociada a la presencia de residuos de ácido siálico glicolilado en la superficie celular.

Reunion Anual Sociedad Argentina de Investigacion Clinica

Lugar: Mar del Plata; Año: 2006;

2006: G.V. RIPOLL, H.G. FARINA, D.E. GOMEZ, D.F. ALONSO.

La desmopresina reduce la colonización metastásica de células de melanoma B16 en ratones transgénicos que sobreexpresan el inhibidor tisular de metaloproteasas-1.

Reunion Anual Sociedad Argentina Investigacion Clinica

Lugar: Mar del Plata; Año: 2006;